Nur Nicholson
CIK 1827317 · Chief Technical Officer · last filed 2026-05-14
"Disclosed insider exposure" sums this person's most-recently-reported share counts across each company they're an insider in, multiplied by the current underlying price. It is not net worth — it misses retail holdings, private investments, real estate, index funds, and any company where the person isn't an SEC-reporting insider. For informational purposes only.
Loading insider history…
Disclosed Exposure
$0
Companies
1
Total Filings
22
Lifetime Open-Market Net
-$2.45M
Holdings By Company
Latest on-record share count from this person's most recent non-derivative Form 4 transaction in each company. Disclosed exposure = shares × current underlying price.
| Symbol | Role | Shares | Price | Disclosed Exposure | Lifetime OM Net | Filings | Latest Filed |
|---|---|---|---|---|---|---|---|
| Apellis Pharmaceuticals, Inc. (APLS) Delisted | Chief Technical Officer | 24,284 | $41.03 | $996.4K | -$2.45M | 22 | 2026-05-14 |
Recent Filings · Page 2 of 3
22 filingsForm 4 transactions across all companies, newest first.
| Filed | Symbol | Action | Net Shares | Net $ | Link |
|---|---|---|---|---|---|
| 2024-03-14 | Apellis Pharmaceuticals, Inc. (APLS) Delisted | Sell (S) | −11,220 | -$645.8K | EDGAR |
| 2024-01-31 | Apellis Pharmaceuticals, Inc. (APLS) Delisted | Sell (S) | −835 | -$53.6K | EDGAR |
| 2024-01-23 | Apellis Pharmaceuticals, Inc. (APLS) Delisted | Sell (S) | −2,593 | -$168.5K | EDGAR |
| 2024-01-17 | Apellis Pharmaceuticals, Inc. (APLS) Delisted | Mixed | +17,651 | -$124.1K | EDGAR |
| 2023-09-19 | Apellis Pharmaceuticals, Inc. (APLS) Delisted | Mixed | −10,631 | -$611.6K | EDGAR |
| 2023-02-22 | Apellis Pharmaceuticals, Inc. (APLS) Delisted | Mixed | +9,061 | -$48.3K | EDGAR |
| 2023-01-30 | Apellis Pharmaceuticals, Inc. (APLS) Delisted | Tax (F) | −551 | -$29.1K | EDGAR |
| 2023-01-24 | Apellis Pharmaceuticals, Inc. (APLS) Delisted | Tax (F) | −2,034 | -$105.9K | EDGAR |
| 2023-01-17 | Apellis Pharmaceuticals, Inc. (APLS) Delisted | Mixed | +20,705 | $0 | EDGAR |
| 2022-02-01 | Apellis Pharmaceuticals, Inc. (APLS) Delisted | Tax (F) | −650 | -$25.1K | EDGAR |
Codes: P = open-market purchase · S = open-market sale · A = grant/award · M = option exercise · F = tax withholding at vest · G = bona-fide gift · D = disposition to issuer · J = other (see filing footnote). Only P / S codes carry directional signal.